Key Insights

Highlights

Success Rate

78% trial completion

Published Results

12 trials with published results (18%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.4%

10 terminated out of 65 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

18%

12 trials in Phase 3/4

Results Transparency

34%

12 of 35 completed with results

Key Signals

12 with results78% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (21)
P 1 (1)
P 2 (16)
P 3 (10)
P 4 (2)

Trial Status

Completed35
Unknown10
Terminated10
Recruiting4
Not Yet Recruiting3
Withdrawn3

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT03455907CompletedPrimary

Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian, Colorectal or Bronchopulmonary Cancer

NCT05700006Completed

Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

NCT05564182Not ApplicableCompleted

High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain

NCT07409948Not ApplicableNot Yet Recruiting

Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

NCT06001125Phase 2Terminated

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

NCT05703178Phase 3Recruiting

Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

NCT04354649Phase 2Recruiting

Immune-Mediated Pathophysiology And Clinical Triage Program

NCT03953157Not ApplicableCompleted

Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors

NCT04754399Phase 2CompletedPrimary

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

NCT04494412Phase 2Recruiting

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

NCT01573442Phase 3CompletedPrimary

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

NCT06746376Not ApplicableNot Yet RecruitingPrimary

Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.

NCT03802578Not ApplicableCompleted

The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients

NCT06530459Phase 2RecruitingPrimary

The MUSE Study for Menopausal Arthralgia

NCT01814397Completed

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

NCT06134050Not ApplicableNot Yet Recruiting

Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy

NCT05448209Not ApplicableCompleted

The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast Cancer

NCT05780450Not ApplicableUnknown

Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

NCT02831582Not ApplicableCompletedPrimary

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

NCT05264649Not ApplicableUnknownPrimary

Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

Scroll to load more

Research Network

Activity Timeline